• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    High Drug Loading Amorphous Solid Dispersions

    Parenteral Drug Delivery Trends

    Selecting the Right Outsourcing Model for Emerging Biotech

    Inhaled Drug Delivery Technology

    The Future of Biologics: Accelerating Production, Reducing Costs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Spark Therapeutics Appoints CTO

    Cryoport Launches ESG Program

    U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail

    Thermo Fisher Scientific Completes Mesa Biotech Acquisition

    Ashfield Engage, Popit Form Digital Monitoring Collaboration
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Solid Dose Market Trends

    CatSci Opens New Site in UK

    Pfizer Partners with Medicines Manufacturing Innovation Center

    C2 Pharma Completes Multiple Regulatory Filings

    Bormioli Opens New Glass Research Center
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Covectra Introduces Next-Gen Serialization Solution

    Bormioli Opens New Glass Research Center

    Centrient Pharmaceuticals to Acquire Astral SteriTech

    Seasonal Vaccine Manufacturing

    PwC Joins Medicines Manufacturing Innovation Centre
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Ashfield Engage, Popit Form Digital Monitoring Collaboration

    AMRI Contributes to Efforts to Increase COVID-19 Vax Supply

    CatSci Opens New Site in UK

    Pfizer Partners with Medicines Manufacturing Innovation Center

    CrownBio & JSR Life Sciences Partner with Cambridge Quantum Computing
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Adare Pharma Solutions

    Syngene

    Baxter BioPharma Solutions

    Alcami

    test company saurabh
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Almac Group

    PCI Pharma Services

    test company saurabh

    Syngene

    Adare Pharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Alvotech, JAMP Pharma Ink Biosim Deal

    Enter into an exclusive partnership for the commercialization of key biosimilars in Canada.

    Alvotech, JAMP Pharma Ink Biosim Deal
    A new partnership sees Alovotech and Jamp Pharma join biosimilar forces in Canada.
    01.15.20
    Alvotech and JAMP Pharma have entered into an agreement for an exclusive partnership to supply and commercialize five biosimilar candidates in the Canadian market. The current market value of the branded sales for these biosimilars is estimated to exceed $2 billion annually.
     
    The partnership agreement includes the exclusive rights for JAMP Pharma to commercialize Alvotech’s biosimilars in Canada, leveraging JAMP’s sales and marketing capabilities and experience in successfully bringing new biosimilars to the fast-growing Canadian market. Under the terms of the agreement, Alvotech will be responsible for full development and commercial supply of the biosimilars from their new state-of-the-art manufacturing facility in Reykjavik, Iceland.
     
    “We are very excited and proud to announce our partnership agreement with JAMP,” said Mark Levick, chief executive officer, Alvotech. “With JAMP’s strong commercial background and experience within the Canadian market, we have further opened our network to help realize our continued goals, which is to benefit patients and give them access to high quality biosimilar medicines.  We look forward to working with JAMP in achieving our milestones and setting a new standard in biosimilars.”
     
    Louis Pilon, chief executive officer, JAMP Pharma Group, said, “We are thrilled with this partnership, as it will allow the JAMP Pharma Group to become a major player and partner in this market while continuing to expand our traditional generic portfolio, which should surpass 500 products by 2022. We now have six biosimilars in our short-term new product pipeline, and this will have a positive impact on both the company’s future and patient access to these important medicines. The JAMP Pharma Group continues to be driven by our desire to offer more affordable options to Canadian patients.”
    Related Searches
    • canada
    • facility
    • marketing
    • pipeline

    Related Breaking News

    • Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
      Alvotech and DKSH Extend Biosimilar Partnership in Asia

      Alvotech and DKSH Extend Biosimilar Partnership in Asia

      Initial pipeline contains biosimilar candidates addressing multiple therapeutic areas.
      Contract Pharma Staff 09.24.20

    • Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
      Alvotech, DKSH Partner to Bring Biosimilar to Asia

      Alvotech, DKSH Partner to Bring Biosimilar to Asia

      Biosimilar of AbbVie’s Humira to be developed and supplied by Alvotech
      03.26.20

    • Bio News | Biologics, Proteins, Vaccines | Biosimilars | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
      Horizon, Glenmark Sign Biomfg. License Agreement

      Horizon, Glenmark Sign Biomfg. License Agreement

      For GS knockout CHO cell line for manufacture of biotherapeutics
      09.30.19


    • Bio News | Biosimilars | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
      Lonza, Celltrion Sign Contract to Manufacture Remsima Drug Substance

      Lonza, Celltrion Sign Contract to Manufacture Remsima Drug Substance

      Lonza’s biologics facility in Singapore to cover EU and U.S. market needs
      09.03.19

    • Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
      Alvotech, Prestige Biopharma Enter New Manufacturing Partnership

      Alvotech, Prestige Biopharma Enter New Manufacturing Partnership

      Alvotech Contract Services to make one of Prestige’s biosimilar candidates
      08.28.19

    • Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
      Alvotech, Cipla Gulf Ink Biosimilar Deal

      Alvotech, Cipla Gulf Ink Biosimilar Deal

      Will partner for the commercialization of key biosimilar in select emerging markets
      07.29.19


    • Bio News | Biologics, Proteins, Vaccines | Biosimilars | Breaking News | Collaborations & Alliances | Facilities | Industry News
      Celltrion, Nan Fung Group Set Up Bio CDMO in China

      Celltrion, Nan Fung Group Set Up Bio CDMO in China

      Establish Vcell Healthcare to develop and commercialize biosimilars; will open biologics manufacturing facility
      07.19.19

    • Bio News | Biologics, Proteins, Vaccines | Biosimilars | Breaking News
      BioPlan Benchmarks the State of Biopharma Mfg.

      BioPlan Benchmarks the State of Biopharma Mfg.

      Participate in the 16th Annual Biopharma Survey Report!
      03.08.19

    • Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Drug Development | Industry News
      Selexis, Turgut Expand Biosimilar Development Pact

      Selexis, Turgut Expand Biosimilar Development Pact

      Under new commercial license agreements, Selexis will help advance Turgut’s pipeline of biosim products in oncology
      02.28.19


    • Bio News | Biosimilars | Breaking News
      Samsung Bioepis, C-Bridge Capital to Develop Next-Gen Biosims in China

      Samsung Bioepis, C-Bridge Capital to Develop Next-Gen Biosims in China

      C-Bridge forms new biopharmaceutical company, AffaMed Therapeutics, which will collaborate with Samsung Bioepis
      02.11.19

    • Bio News | Biosimilars | Breaking News | Industry News
      Alvotech Raises $300M to Fuel Biosimilar Growth

      Alvotech Raises $300M to Fuel Biosimilar Growth

      Current pipeline consists of six biosimilar monoclonal antibodies aimed at treating cancer, autoimmune, inflammatory and other diseases
      01.22.19

    • Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
      Sandoz Enters Biosimilars Deal with Gan & Lee Pharmaceutical in China

      Sandoz Enters Biosimilars Deal with Gan & Lee Pharmaceutical in China

      Covers biosimilar insulins in early and clinical development for the top three selling branded insulins by sales: glargine, lispro and aspart
      12.28.18


    • Biosimilars | Breaking News | Drug Development | Industry News
      Alvotech, Fuji Pharma Expand Biosimilars Alliance

      Alvotech, Fuji Pharma Expand Biosimilars Alliance

      Fuji invests $50 million in Alvotech, expands development and commercialization of biosimilars in Japan
      12.18.18

    • Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
      Alvotech and Fuji Pharma Enter Biosimilars Tie-up

      Alvotech and Fuji Pharma Enter Biosimilars Tie-up

      Partnership gives Fuji Pharma a leading position in the Japanese biosimilar market
      11.20.18

    • Bio News | Biologics, Proteins, Vaccines | Biosimilars | Breaking News | cGMP Manufacture | Industry News
      REPORT: Biopharma Mfg. Capacity and Production

      REPORT: Biopharma Mfg. Capacity and Production

      222 biopharma companies surveyed plus130 industry vendors and direct suppliers of materials
      08.17.18

    Trending
    • Catalent Acquires Delphi Genetics
    • Inside A Vaccine Trial
    • Pfizer Selects Seven Bridges To Support RNA Sequencing Data
    • Pfizer Partners With Medicines Manufacturing Innovation Center
    • ICON Acquires Medpass
    Breaking News
    • Spark Therapeutics Appoints CTO
    • Cryoport Launches ESG Program
    • U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail
    • Thermo Fisher Scientific Completes Mesa Biotech Acquisition
    • Ashfield Engage, Popit Form Digital Monitoring Collaboration
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • High Drug Loading Amorphous Solid Dispersions
    • Parenteral Drug Delivery Trends
    • Selecting the Right Outsourcing Model for Emerging Biotech
    • Inhaled Drug Delivery Technology
    • The Future of Biologics: Accelerating Production, Reducing Costs
    • Business Intelligence For (and From) the Lab
    • Communicating Your Contracting Priorities to Your Drug Company Customers
    • COVID-19 Impact Report
    • The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Preliminary Study Links Markers of Impaired Bone Health to Vegan Diet
    Refined Grains Linked to Heart Attack Risk, Early Death
    Kappa Bioscience Extends Research Partnership For COVID-19 Research
    Coatings World

    Latest Breaking News From Coatings World

    Nippon Paint Marine Wins Korea Export Award
    Universal Display Corporation, PPG Expand Global Production of UniversalPHOLED Materials
    PPG Introduces Premium Iso-free Primer Surfacer, Catalyst
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    January AI Raises $8.8 Million in New Funding
    FDA Clears Ava Fertility Tracking Wearable Device
    First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Spark Therapeutics Appoints CTO
    Cryoport Launches ESG Program
    U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The Top Beauty Products of 2021, According to HelloGiggles
    Estée Lauder Taps Ana de Armas as Global Brand Ambassador
    Sephora Announces Significant Expansion
    Happi

    Latest Breaking News From Happi

    ACI Urges Senate to Approve Regan as EPA Administrator
    Estée Lauder Signs Actress Ana de Armas
    GUM Recalls Oral Spray
    Ink World

    Latest Breaking News From Ink World

    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Marshall & Bruce Adds Koenig & Bauer Rapida 106 41-Inch Seven-Color Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    FTA converts Forum & INFOFLEX to virtual events
    Xeikon launches two new digital label printing presses
    UFlex adds capacity in packaging films
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Texas Medical Technology Partners with My Protect Kit
    Mexico City Single-Use Plastics Ban Leads to Tampon Shortage
    Believe Diapers Launch in U.S.
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System
    Kaia Health Unveils Next-Gen Complete MSK Care Solutions
    First Implantation of CTL Amedica's Minimally Invasive Flex Tower
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login